As of 2025-06-30, the Relative Valuation of ImmunoGen Inc (IMGN) is (7.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on Relative Valuation is -123.4%.
The range of the Relative Valuation is (6.17) - (7.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.1x - 28.0x | 25.1x |
| Forward P/E multiples | 23.4x - 39.6x | 30.4x |
| Fair Price | (6.17) - (7.37) | (7.30) |
| Upside | -119.7% - -123.6% | -123.4% |
| Date | P/E |